204
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Understanding the Influence of Antipsychotic Drugs on Global Methylation Events and Its Relevance in Treatment Response

, , , &
Pages 233-247 | Received 12 Jul 2017, Accepted 18 Oct 2017, Published online: 18 Jan 2018

References

  • Ackenheil M , WeberK . Differing response to antipsychotic therapy in schizophrenia: pharmacogenomic aspects . Dialogues Clin. Neurosci.6 ( 1 ), 71 ( 2004 ).
  • Smith E , WestonCA , LiebermanA . Schizophrenia (maintenance treatment) . BMJ Clin. Evid. 2009 , pii:1007 ( 2009 ).
  • Broekema W , De GrootI , Van HartenP . Simultaneous prescribing of atypical antipsychotics, conventional antipsychotics and anticholinergics – a European study . Pharm. World Sci.29 ( 3 ), 126 – 130 ( 2007 ).
  • Razzouk D , KayoM , SousaAet al. The impact of antipsychotic polytherapy costs in the public health care in Sao Paulo, Brazil . PLoS ONE10 ( 4 ), e0124791 ( 2015 ).
  • Harrington M , LelliottP , PatonC , OkochaC , DuffettR , SenskyT . The results of a multi-centre audit of the prescribing of antipsychotic drugs for in-patients in the UK . The Psychiatrist26 ( 11 ), 414 – 418 ( 2002 ).
  • Jerrell JM , McintyreRS . Adverse events in children and adolescents treated with antipsychotic medications . Hum. Psychopharmacol.23 ( 4 ), 283 – 290 ( 2008 ).
  • Comer JS , OlfsonM , MojtabaiR . National trends in child and adolescent psychotropic polypharmacy in office-based practice, 1996–2007 . J. Am. Acad. Child Adolesc. Psychiatry49 ( 10 ), 1001 – 1010 ( 2010 ).
  • Barbui C , NosèM , MazziMAet al. Persistence with polypharmacy and excessive dosing in patients with schizophrenia treated in four European countries . Int. Clin. Psychopharmacol.21 ( 6 ), 355 – 362 ( 2006 ).
  • Fleischhacker WW , UchidaH . Critical review of antipsychotic polypharmacy in the treatment of schizophrenia . Int. J. Neuropsychopharmacol.17 ( 7 ), 1083 – 1093 ( 2014 ).
  • Rojo LE , GasparPA , SilvaHet al. Metabolic syndrome and obesity among users of second generation antipsychotics: a global challenge for modern psychopharmacology . Pharmacol. Res.101 , 74 – 85 ( 2015 ).
  • Eum S , LeeAM , BishopJR . Pharmacogenetic tests for antipsychotic medications: clinical implications and considerations . Dialogues Clin. Neurosci.18 ( 3 ), 323 ( 2016 ).
  • Gressier F , PorcelliS , CalatiR , SerrettiA . Pharmacogenetics of clozapine response and induced weight gain: a comprehensive review and meta-analysis . Eur. Neuropsychopharmacol.26 ( 2 ), 163 – 185 ( 2016 ).
  • Ventola CL . Role of pharmacogenomic biomarkers in predicting and improving drug response: part 1: the clinical significance of pharmacogenetic variants . PT38 ( 9 ), 545 ( 2013 ).
  • Ivanov M , KacevskaM , Ingelman-SundbergM . Epigenomics and interindividual differences in drug response . Clin. Pharmacol. Ther.92 ( 6 ), 727 – 736 ( 2012 ).
  • Swathy B , BanerjeeM . Understanding epigenetics of schizophrenia in the backdrop of its antipsychotic drug therapy . Epigenomics9 ( 5 ), 721 – 736 ( 2017 ).
  • Ingelman-Sundberg M , CascorbiI . Pharmacogenomic or -epigenomic biomarkers in drug treatment: two sides of the same medal?Clin. Pharmacol. Ther.99 ( 5 ), 478 – 480 ( 2016 ).
  • Sarabi MM , NaghibalhossainiF . Association of DNA methyltransferases expression with global and gene-specific DNA methylation in colorectal cancer cells . Cell Biochem. Funct.33 ( 7 ), 427 – 433 ( 2015 ).
  • Garzon R , LiuS , FabbriMet al. MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1 . Blood113 ( 25 ), 6411 – 6418 ( 2009 ).
  • Wu X , ZhangY . TET-mediated active DNA demethylation: mechanism, function and beyond . Nat. Rev. Genet.18 ( 9 ), 517 – 534 ( 2017 ).
  • Wu H , ZhangY . Mechanisms and functions of Tet protein-mediated 5-methylcytosine oxidation . Genes Dev.25 ( 23 ), 2436 – 2452 ( 2011 ).
  • Morita S , HoriiT , KimuraM , OchiyaT , TajimaS , HatadaI . miR-29 represses the activities of DNA methyltransferases and DNA demethylases . Int. J. Mol. Sci.14 ( 7 ), 14647 – 14658 ( 2013 ).
  • Niu M , GaoD , WenQet al. MiR-29c regulates the expression of miR-34c and miR-449a by targeting DNA methyltransferase 3a and 3b in nasopharyngeal carcinoma . BMC Cancer16 ( 1 ), 218 ( 2016 ).
  • Vijayan NN , MathewA , BalanSet al. Antipsychotic drug dosage and therapeutic response in schizophrenia is influenced by ABCB1 genotypes: a study from a south Indian perspective . Pharmacogenomics13 ( 10 ), 1119 – 1127 ( 2012 ).
  • Milutinovic S , D’alessioAC , DetichN , SzyfM . Valproate induces widespread epigenetic reprogramming which involves demethylation of specific genes . Carcinogenesis28 ( 3 ), 560 – 571 ( 2007 ).
  • Saradalekshmi KR , NeethaNV , SathyanS , NairIV , NairCM , BanerjeeM . DNA methyl transferase (DNMT) gene polymorphisms could be a primary event in epigenetic susceptibility to schizophrenia . PLoS ONE9 ( 5 ), e98182 ( 2014 ).
  • Bustin SA , BenesV , GarsonJAet al. The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments . Clin. Chem.55 ( 4 ), 611 – 622 ( 2009 ).
  • Gerets H , TilmantK , GerinBet al. Characterization of primary human hepatocytes, HepG2 cells, and HepaRG cells at the mRNA level and CYP activity in response to inducers and their predictivity for the detection of human hepatotoxins . Cell Biol. Toxicol.28 ( 2 ), 69 – 87 ( 2012 ).
  • Raeder MB , Fern⊘J , Vik-MoAO , SteenVM . SREBP activation by antipsychotic-and antidepressant-drugs in cultured human liver cells: relevance for metabolic side-effects?Mol. Cell. Biochem.289 ( 1–2 ), 167 – 173 ( 2006 ).
  • Bespalov A , MüllerR , ReloAL , HudzikT . Drug tolerance: a known unknown in translational neuroscience . Trends Pharmacol. Sci.37 ( 5 ), 364 – 378 ( 2016 ).
  • Swathy B , SaradalekshmiKR , NairIV , NairC , BanerjeeM . Pharmacoepigenomic responses of antipsychotic drugs on pharmacogenes are likely to be modulated by miRNAs . Epigenomics9 ( 6 ), 811 – 821 ( 2017 ).
  • Melas PA , RogdakiM , ÖsbyU , SchallingM , LavebrattC , EkströmTJ . Epigenetic aberrations in leukocytes of patients with schizophrenia: association of global DNA methylation with antipsychotic drug treatment and disease onset . FASEB J.26 ( 6 ), 2712 – 2718 ( 2012 ).
  • Shimabukuro M , SasakiT , ImamuraAet al. Global hypomethylation of peripheral leukocyte DNA in male patients with schizophrenia: a potential link between epigenetics and schizophrenia . J. Psychiatr. Res.41 ( 12 ), 1042 – 1046 ( 2007 ).
  • Bromberg A , LevineJ , NemetzB , BelmakerR , AgamG . No association between global leukocyte DNA methylation and homocysteine levels in schizophrenia patients . Schizophr. Res.101 ( 1 ), 50 – 57 ( 2008 ).
  • Melka MG , LauferBI , McdonaldPet al. The effects of olanzapine on genome-wide DNA methylation in the hippocampus and cerebellum . Clin. Epigenetics6 ( 1 ), 1 – 12 ( 2014 ).
  • Veldic M , CarunchoH , LiuWet al. DNA-methyltransferase 1 mRNA is selectively overexpressed in telencephalic GABAergic interneurons of schizophrenia brains . Proc. Natl Acad. Sci. USA101 ( 1 ), 348 – 353 ( 2004 ).
  • Zhubi A , VeldicM , PuriNet al. An upregulation of DNA-methyltransferase 1 and 3a expressed in telencephalic GABAergic neurons of schizophrenia patients is also detected in peripheral blood lymphocytes . Schizophr. Res.111 ( 1 ), 115 – 122 ( 2009 ).
  • Amodio N , LeottaM , BellizziDet al. DNA-demethylating and anti-tumor activity of synthetic miR-29b mimics in multiple myeloma . Oncotarget3 ( 10 ), 1246 – 1258 ( 2012 ).
  • Braconi C , KogureT , ValeriNet al. microRNA-29 can regulate expression of the long non-coding RNA gene MEG3 in hepatocellular cancer . Oncogene30 ( 47 ), 4750 – 4756 ( 2011 ).
  • Fabbri M , GarzonR , CimminoAet al. MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B . Proc. Natl Acad. Sci. USA104 ( 40 ), 15805 – 15810 ( 2007 ).
  • Perkins DO , JeffriesCD , JarskogLFet al. microRNA expression in the prefrontal cortex of individuals with schizophrenia and schizoaffective disorder . Genome Biol.8 ( 2 ), R27 ( 2007 ).
  • Gardiner E , BeveridgeN , WuJet al. Imprinted DLK1-DIO3 region of 14q32 defines a schizophrenia-associated miRNA signature in peripheral blood mononuclear cells . Mol. Psychiatry17 ( 8 ), 827 – 840 ( 2012 ).
  • Santarelli DM , LiuB , DuncanCEet al. Gene-microRNA interactions associated with antipsychotic mechanisms and the metabolic side effects of olanzapine . Psychopharmacology227 ( 1 ), 67 – 78 ( 2013 ).
  • Sullivan PF , FanC , PerouCM . Evaluating the comparability of gene expression in blood and brain . Am. J. Med. Genet. B Neuropsychiatr. Genet.141 ( 3 ), 261 – 268 ( 2006 ).
  • Tylee DS , KawaguchiDM , GlattSJ . On the outside, looking in: a review and evaluation of the comparability of blood and brain “-omes” . Am. J. Med. Genet. B Neuropsychiatr. Genet.162 ( 7 ), 595 – 603 ( 2013 ).
  • Lai C , LeeS , ScarrEet al. Aberrant expression of microRNAs as biomarker for schizophrenia: from acute state to partial remission, and from peripheral blood to cortical tissue . Transl. Psychiatry6 ( 1 ), e717 ( 2016 ).
  • Swathy B , BanerjeeM . Haloperidol induces pharmacoepigenetic response by modulating miRNA expression, global DNA methylation and expression profiles of methylation maintenance genes and genes involved in neurotransmission in neuronal cells . PLoS ONE12 ( 9 ), e0184209 ( 2017 ).
  • Perneger TV . What’s wrong with Bonferroni adjustments?BMJ316 ( 7139 ), 1236 – 1238 ( 1998 ).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.